Pharmacological cardioversion of atrial fibrillation: current management and treatment options.

摘要: Atrial fibrillation (AF) is the most common form of arrhythmia, carrying high social costs. It usually first seen by general practitioners or in emergency departments. Despite availability consensus guidelines, considerable variations exist treatment practice, especially outside specialised cardiological settings. Cardioversion to sinus rhythm aims to: (i) restore atrial contribution ventricular filling/output; (ii) regularise rate; and (iii) interrupt remodelling. always requires careful assessment potential proarrhythmic thromboembolic risks, this translates into need personalise decisions. Among many clinical variables that affect strategy selection, time from onset crucial.